Jaqueline Scholz | Prevention – Public Politic | Best Research Article Award

Dr. Jaqueline Scholz | Prevention – Public Politic | Best Research Article Award

Dr. Jaqueline Ribeiro Scholz, MD, PhD, is a distinguished cardiologist and academic based at the Instituto do Coração (InCor), Universidade de São Paulo, Brazil. Renowned for her pioneering work in tobacco control, Dr. Scholz has made significant contributions to cardiovascular health through clinical innovation, research, and public policy. She directs the Smoking Cessation Program at InCor, offering advanced treatment modalities for tobacco dependency and developing innovative digital tools such as the PAF software and COVID-19 cessation chatbot. Her expertise has been instrumental at state, national, and global levels, including collaborations with the World Health Organization’s Tobacco or Health Program. Dr. Scholz’s commitment extends beyond clinical practice into impactful public health advocacy, contributing to legislation and preventive programs aimed at reducing tobacco-related harm globally. Her work aligns closely with international efforts to combat non-communicable diseases, positioning her as a global leader in preventive cardiology and tobacco cessation.

Profile

🎓 Education

Dr. Jaqueline Scholz received her medical training and specialized education entirely at the prestigious Universidade de São Paulo, Brazil. She completed her Residency in Cardiology at the Instituto do Coração (InCor), gaining extensive clinical expertise in cardiovascular medicine. Pursuing her academic ambitions, she specialized further with a degree in Cardiopneumology at Faculdade de Medicina da USP, equipping her with a comprehensive understanding of cardiopulmonary diseases and their systemic impacts. In 2002, Dr. Scholz earned her PhD in Cardiology from Universidade de São Paulo, focusing her research on the intersection of tobacco use and cardiovascular health. Her academic foundation has underpinned her multidisciplinary approach to clinical care, research, and public health advocacy, blending cutting-edge science with practical interventions aimed at tobacco cessation. This strong educational background has positioned her as a respected authority in preventive cardiology, with a special emphasis on combating the global tobacco epidemic.

🧪 Experience

Dr. Jaqueline Scholz has over three decades of progressive experience in clinical cardiology, research, and public health policy. Since 2003, she has served as Director of the Smoking Cessation Program at Instituto do Coração (InCor), São Paulo, leading innovative cessation strategies, including the development of patient-support technologies like the PAF software and a COVID-19 chatbot for smokers. Between 1995 and 1996, she contributed her expertise to the São Paulo State Health Department’s Commission on Tobacco Control, directly influencing state-level anti-tobacco policies and campaigns. Earlier, from 1993 to 1996, Dr. Scholz served as a medical collaborator with the World Health Organization’s Tobacco or Health Program, participating in global strategy development for tobacco reduction. Her multifaceted career bridges clinical innovation, technology integration, public health leadership, and international policy advising, marking her as a key figure in tobacco control and preventive cardiovascular care on both national and global stages.

🏅 Awards and Honors

Although specific awards are not listed, Dr. Jaqueline Scholz’s career is marked by distinguished recognition through her leadership roles and global collaborations. Being appointed as Director of the Smoking Cessation Program at one of Brazil’s most prestigious cardiology institutes reflects professional excellence. Her selection to serve on the São Paulo State Commission on Tobacco Control and as a collaborator with the World Health Organization underscores her expertise and international reputation in tobacco control. Her innovative development of patient-centric tools such as the PAF software and the COVID-19 cessation chatbot has further garnered professional acclaim. Dr. Scholz’s extensive involvement with leading health organizations and her continuous contributions to public health policy highlight the respect and trust she commands within the cardiovascular and tobacco control communities. Her work aligns with the global health agenda, earning her recognition as a leading advocate and innovator in preventive cardiology and tobacco harm reduction.

🔬 Research Focus

Dr. Jaqueline Scholz’s research focuses on tobacco dependency treatment, smoking cessation strategies, and their direct impact on cardiovascular health outcomes. Her work bridges clinical practice, digital health innovation, and public health policy to develop effective, scalable interventions for tobacco users. At InCor, she leads studies on novel cessation methodologies, including the integration of digital platforms like the PAF software and automated chatbots to enhance patient support, particularly during public health crises like COVID-19. She has contributed to global tobacco control frameworks through collaborations with the World Health Organization, emphasizing the cardiovascular consequences of smoking and advocating for robust public health responses. Her research also informs state-level policy development, contributing to evidence-based regulations and campaigns targeting smoking reduction. Dr. Scholz’s work aims to reduce the global burden of cardiovascular diseases by addressing one of its leading risk factors—tobacco use—through innovative, patient-centered, and policy-driven approaches.

Conclusion

Dr. Jaqueline Scholz is a globally recognized cardiologist whose innovative clinical work, pioneering research, and leadership in public health policy have made substantial contributions to tobacco cessation and cardiovascular health, aligning with global efforts to reduce smoking-related morbidity and mortality.

Publications
  • Nicotine Dependence in a Banned Market: Biomarker Evidence from E-Cigarette Users in São Paulo, Brazil

    International Journal of Environmental Research and Public Health
    2025-06-19 | Journal article
    CONTRIBUTORS: Jaqueline Ribeiro Scholz; Elaine Cristine D’Amico; Juliana Takitane; Daniele Mayumi Sinagawa; João Mauricio Castaldelli-Maia; Marcelo Filonzi dos Santos; Rodrigo Alves de Oliveira; Guilherme Vinicius Marques; Eric Nagamine Lima; Diana Fernanda Lasso Rodriguez et al.
  • Smoking cessation decreases arterial blood pressure in hypertensive smokers: A subgroup analysis of the randomized controlled trial GENTSMOKING

    Tobacco Induced Diseases
    2024-05-16 | Journal article
    CONTRIBUTORS: Patricia V. Gaya; Guilherme Wesley P. Fonseca; Lucas Tsuyoshi Tanji; Tania O. Abe; Maria Janieire N. N. Alves; Paulo Caleb Junior de Lima Santos; Fernanda M. Consolim Colombo; Jaqueline R. Scholz
  • Posicionamento da Sociedade Brasileira de Cardiologia sobre o Uso de Dispositivos Eletrônicos para Fumar – 2024

    Arquivos Brasileiros de Cardiologia
    2024-02-08 | Journal article
    CONTRIBUTORS: Jaqueline R. Scholz; Deborah Carvalho Malta; Antonio Aurélio de Paiva Fagundes, Júnior; Ricardo Pavanello; Gerson Luiz Bredt, Júnior; Mário de Seixas Rocha
  • Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion

    Frontiers in Pharmacology
    2022 | Journal article

    EID:

    2-s2.0-85135484127

    Part of ISSN: 16639812
    CONTRIBUTORS: Tomaz, P.R.X.; Gonçalves, T.S.; Santos, J.R.; Scholz, J.; Abe, T.O.; Gaya, P.V.; Figueiredo, E.C.; de Faria, H.D.; Martins, I.; Pego, A.M.F. et al

Paula San Martín González | Health Sciences | Best Researcher Award

Dr. Paula San Martín González | Health Sciences | Best Researcher Award

Paula San Martín González, born in Salamanca, Spain, is a dedicated academic and healthcare professional currently serving as Profesora Ayudante Doctora at Universidad Pontificia de Salamanca. With a solid foundation in nursing, she has steadily advanced through both clinical and academic pathways. She holds a PhD in Human and Social Sciences and multiple master’s degrees in oncology, critical care, and emergency nursing, as well as in teaching secondary education. She has also earned postgraduate expertise in leadership, management, and ultrasound in nursing care. Since 2017, she has been deeply involved in higher education, delivering over 20 courses in nursing and health sciences. Recognized with the DOCENTIA award, her contributions span simulation-based teaching, innovation in health education, and interdisciplinary learning. Paula continues to enrich healthcare pedagogy through teaching, research, and curriculum development in simulation-based clinical practice.

Profile

🎓 Education

Paula San Martín González completed her Bachelor’s in Nursing at Universidad Pontificia de Salamanca in 2014. She pursued specialized education with three official master’s degrees: one in Palliative Care for Oncology Patients (University of Salamanca, 2016), another in Critical and Emergency Nursing (University of León, 2017), and a third in Secondary and Vocational Education Teaching (UPSA). Additionally, she earned postgraduate qualifications in Leadership in Nursing Services (UDIMA, 2020) and Clinical Ultrasound for Nursing (Universidad Católica de Ávila, 2024). Her academic journey culminated in a PhD in Human and Social Sciences from Universidad Pontificia de Salamanca in 2022. Notably, she also became an Instructor in Advanced Clinical Simulation (UCAM, 2020), further deepening her pedagogical capabilities. Her educational background reflects a harmonious blend of clinical, academic, and teaching excellence, equipping her to bridge the gap between theoretical learning and healthcare practice with precision and empathy.

🧪 Experience

Paula has accumulated diverse experience in clinical and academic settings. She began her career as a nurse at Fundación Hospital General de la Santísima Trinidad (2015–2016) and later worked at Hospital Universitario Marqués de Valdecilla (2016–2017). In 2017, she transitioned to academia, joining Universidad Pontificia de Salamanca as a full-time Profesora Ayudante, later promoted to Profesora Ayudante Doctora in 2024. Her teaching portfolio spans over 25 university-level nursing and education courses, including mental health nursing, health alterations, community nursing, clinical practicums, and simulation-based learning. She also taught in collaborative programs like the University of Experience and courses at the University of Burgos. Alongside teaching, she has delivered workshops and seminars on simulation, leadership, and innovation in nursing education. Her consistent progression from bedside care to academic excellence highlights a commitment to training future nursing professionals through innovation, clinical insight, and dedication.

🏅 Awards and Honors

Paula San Martín González has been recognized for her exceptional teaching contributions with the DOCENTIA Award granted by Universidad Pontificia de Salamanca in 2024. This prestigious award acknowledges excellence in university teaching and reflects her high-quality performance in classroom instruction and academic mentorship. Her teaching activity from 2017 to 2021 was evaluated as Excellent by the ACSUCYL/ANECA accreditation bodies, affirming her effectiveness and impact as an educator. Additionally, she earned positive accreditation for the rank of Profesor Ayudante Doctor in 2024, further validating her professional competence and qualifications within Spain’s higher education system. Her commitment to innovative teaching methodologies, such as clinical simulation and patient-standardized training, has also contributed to her recognition as a leader in educational innovation. These accolades underscore her influence in the academic community and her drive to elevate the standards of nursing education.

🔬 Research Focus

Paula’s research centers on clinical simulation, educational innovation in nursing, leadership development, and digital health literacy. She is especially invested in exploring how simulation methodologies improve the practical training of nursing students. Her published work includes book chapters on simulation-based instruction using standardized patients, the integration of social media in health education, and strategies to foster entrepreneurial leadership among health sciences students. These contributions reflect her broader goal to blend academic rigor with technological advancements in pedagogy. She is a leading author in projects linked to educational transformation, particularly through simulation and interdisciplinary collaboration. Moreover, her research supports reflective, student-centered learning models that promote critical thinking, self-efficacy, and adaptive clinical decision-making. Her engagement with simulation-based projects aligns with current trends in nursing education and contributes to a deeper, evidence-based understanding of its efficacy in real-world preparedness for healthcare professionals.

Conclusion

Paula San Martín González exemplifies a modern nursing educator whose blend of clinical expertise, academic excellence, and pedagogical innovation—particularly through simulation-based learning—positions her as a transformative force in healthcare education.

Publications
  • Promotion of Healthy Habits in Adolescents: An Interdisciplinary Study on Motivation Towards Physical Education, Mediterranean Diet and Physical Activity

    Behavioral Sciences
    2025-06 | Journal article | Author
    CONTRIBUTORS: Paula San Martín González; José Enrique Moral García; Mario Amatria Jiménez; Rubén Arroyo Del Bosque
  • Prevalence of burnout syndrome among veterinarians in SpainJournal of the American Veterinary Medical Association

    2023-02-07 | Journal article
    Part ofISSN: 0003-1488
    CONTRIBUTORS: Álvaro San Martín González; Paula San Martín González; María-Prado Míguez-Santiyán; Francisco Soler Rodríguez; Marcos Pérez-López
  • Manejo del dolor en el paciente terminal oncológico

    Cuidados en salud en iberoamérica
    2022 | Journal article
    CONTRIBUTORS: Paula San Martín González

Georg Hafer | Allgemeine Innere Medizin | Best Researcher Award

Dr. Georg Hafer | Allgemeine Innere Medizin | Best Researcher Award

Dr. med. Georg Hafer, born on August 22, 1976, in Paderborn, Germany, is a distinguished internal medicine specialist currently serving as the Medical Director of the Medical Ambulatory Clinic at Kantonsspital St. Gallen, Switzerland. He completed his medical degree at Justus-Liebig-University Giessen and earned his doctorate in 2008 with high honors. Dr. Hafer has held various clinical roles, progressing from Assistant Physician to Senior Consultant across multiple Swiss institutions. He holds board certification in General Internal Medicine (FMH) and has additional training in psychosomatic medicine and abdominal sonography. With a strong foundation in emergency, internal, surgical, and geriatric psychiatry care, his approach integrates both physical and psychological aspects of health. His career is marked by commitment to interdisciplinary care, patient-centered practice, and continuous professional development. Married and a father of three, he balances his professional responsibilities with a dedication to family life and ethical medical leadership.

Profile

🎓 Education

Dr. Georg Hafer began his academic journey with the Allgemeine Hochschulreife from Neue Oberschule Braunschweig in 1996. He served as a paramedic during his national civil service before entering medical school. From 1997 to 2004, he studied human medicine at Justus-Liebig-University in Giessen, Germany, successfully completing all three stages of the state medical examination. He was licensed to practice medicine in November 2004. His doctoral thesis, completed in 2008, focused on the effects of anesthetics on leukocyte surface receptor expression, earning the distinction “sehr gut.” He further qualified as a specialist in General Internal Medicine (FMH) in 2012. Dr. Hafer expanded his expertise through certified training in psychosomatic and psychosocial medicine (SAPPM) and abdominal sonography, becoming a certified SGUM tutor. His education reflects a commitment to lifelong learning, with academic achievements that integrate foundational science, clinical training, and specialized interdisciplinary competence.

🧪 Experience

Dr. Hafer’s clinical journey spans over two decades in Switzerland, beginning in 2005 as an Assistant Physician at the Kreisspital Muri. He gained experience in internal medicine, geriatrics, surgery, and psychiatry at prestigious institutions including the University Psychiatric Hospital Zurich, Stadtspital Waid, and Kantonsspital St. Gallen. His responsibilities evolved from clinical assistant to Senior Consultant and ultimately to Medical Director. Notably, he led emergency and observation units at Spital Flawil and held key roles in the internal medicine departments at Rorschach and St. Gallen. His practice included intensive care, geriatric, neurological, and ambulatory care. Since 2021, he has served as the leading physician and medical director of the Medical Ambulatory Clinic at Kantonsspital St. Gallen. Dr. Hafer is known for his clinical leadership, team collaboration, and comprehensive patient care, integrating somatic and psychosocial dimensions into medical decision-making and administration.

🏅 Awards and Honors

While the curriculum vitae of Dr. Georg Hafer does not list formal awards or honorary recognitions, his academic and professional milestones highlight a career of merit-based progression and institutional trust. He earned his doctorate in medicine in 2008 with the distinction “sehr gut,” recognizing his scientific contribution to anesthesiology research. He was entrusted with roles of increasing responsibility, from assistant physician to leading physician, across various Swiss hospitals—an implicit acknowledgment of his competence, reliability, and leadership. His certifications, such as FMH in General Internal Medicine and recognized expertise in psychosomatic medicine and abdominal sonography, underscore professional excellence and peer acknowledgment. In clinical institutions such as Kantonsspital St. Gallen and Spital Rorschach, he has held key administrative and training roles, reflecting institutional confidence in his judgment and skills. These achievements speak to a career distinguished by respect, performance, and trust in the Swiss healthcare system.

🔬 Research Focus

Dr. Hafer’s research, as reflected in his doctoral work, centers on the immunological effects of anesthetic agents, examining how substances like ketamine and propofol affect leukocyte surface receptor expression. This study bridges immunology, pharmacology, and critical care—an area vital to understanding inflammatory responses during anesthesia and critical illness. While his later clinical trajectory emphasizes patient care over academia, the scientific rigor of his thesis illustrates a strong foundation in evidence-based medicine. His additional certifications in psychosomatic medicine suggest ongoing interest in the intersection between mental and physical health, a topic gaining increasing relevance in modern internal medicine. Through roles in emergency and intensive medicine, Dr. Hafer has likely contributed to clinical knowledge-sharing, protocol development, and interdisciplinary practice models. Though not extensively published, his research and clinical leadership roles suggest a translational approach—applying scientific insight to optimize diagnostics, care strategies, and long-term health outcomes.

Conclusion

Dr. Georg Hafer exemplifies the integration of clinical excellence, scientific inquiry, and holistic care in internal medicine, progressing through Switzerland’s top hospitals to become a respected leader known for compassionate patient care, interdisciplinary competence, and ethical practice.

 

Publications